Miremadi A - Search Results

1

Pathological validation and significance of micrometastasis in sentinel nodes in primary breast cancer.

Rampaul RS, Miremadi A, Pinder SE, Lee A, Ellis IO. Rampaul RS, et al. Among authors: miremadi a. Breast Cancer Res. 2001;3(2):113-6. doi: 10.1186/bcr282. Epub 2001 Jan 23. Breast Cancer Res. 2001. PMID: 11250757 Free PMC article. Review.

2

Neuroendocrine differentiation and prognosis in breast adenocarcinoma.

Miremadi A, Pinder SE, Lee AH, Bell JA, Paish EC, Wencyk P, Elston CW, Nicholson RI, Blamey RW, Robertson JF, Ellis IO. Miremadi A, et al. Histopathology. 2002 Mar;40(3):215-22. doi: 10.1046/j.1365-2559.2002.01336.x. Histopathology. 2002. PMID: 11895486

3

Prognostic significance of BRCA1 expression in sporadic breast carcinomas.

Lambie H, Miremadi A, Pinder SE, Bell JA, Wencyk P, Paish EC, Macmillan RD, Ellis IO. Lambie H, et al. Among authors: miremadi a. J Pathol. 2003 Jun;200(2):207-13. doi: 10.1002/path.1348. J Pathol. 2003. PMID: 12754741

4

An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer.

Teschendorff AE, Miremadi A, Pinder SE, Ellis IO, Caldas C. Teschendorff AE, et al. Among authors: miremadi a. Genome Biol. 2007;8(8):R157. doi: 10.1186/gb-2007-8-8-r157. Genome Biol. 2007. PMID: 17683518 Free PMC article.

5

Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinoma.

Noble F, Lloyd MA, Turkington R, Griffiths E, O'Donovan M, O'Neill JR, Mercer S, Parsons SL, Fitzgerald RC, Underwood TJ; OCCAMS consortium. Noble F, et al. Br J Surg. 2017 Dec;104(13):1816-1828. doi: 10.1002/bjs.10627. Epub 2017 Sep 25. Br J Surg. 2017. PMID: 28944954 Free PMC article.

6

Cancer genetics of epigenetic genes.

Miremadi A, Oestergaard MZ, Pharoah PD, Caldas C. Miremadi A, et al. Hum Mol Genet. 2007 Apr 15;16 Spec No 1:R28-49. doi: 10.1093/hmg/ddm021. Hum Mol Genet. 2007. PMID: 17613546 Review.

7

Feasibility of combined screening for upper gastrointestinal adenocarcinoma risk by serology and Cytosponge testing: the SUGAR study.

Xu Y, Miremadi A, Link A, Malfertheiner P, Fitzgerald RC, Bornschein J. Xu Y, et al. Among authors: miremadi a. J Clin Pathol. 2019 Dec;72(12):825-829. doi: 10.1136/jclinpath-2019-205700. Epub 2019 Jun 24. J Clin Pathol. 2019. PMID: 31235543 Free PMC article.

8

Range of pathologies diagnosed using a minimally invasive capsule sponge to evaluate patients with reflux symptoms.

Paterson AL, Lao-Sirieix P, O'Donovan M, Debiram-Beecham I, di Pietro M, Miremadi A, Attwood SE, Walter FM, Sasieni PD, Fitzgerald RC; BEST and BEST2 study groups. Paterson AL, et al. Among authors: miremadi a. Histopathology. 2017 Jan;70(2):203-210. doi: 10.1111/his.13039. Epub 2016 Oct 12. Histopathology. 2017. PMID: 27417524 Clinical Trial.

9

Endoscopic tumour morphology impacts survival in adenocarcinoma of the oesophagus.

Knight WRC, McEwen R, Byrne BE, Habib W, Bott R, Zylstra J, Mahadeva U, Gossage JA; Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Consortium. Knight WRC, et al. Eur J Surg Oncol. 2020 Dec;46(12):2257-2261. doi: 10.1016/j.ejso.2020.07.003. Epub 2020 Jul 28. Eur J Surg Oncol. 2020. PMID: 32814680

10

The utility of P53 immunohistochemistry in the diagnosis of Barrett's oesophagus with indefinite for dysplasia.

Januszewicz W, Pilonis ND, Sawas T, Phillips R, O'Donovan M, Miremadi A, Malhotra S, Tripathi M, Blasko A, Katzka DA, Fitzgerald RC, di Pietro M. Januszewicz W, et al. Among authors: miremadi a. Histopathology. 2022 Jun;80(7):1081-1090. doi: 10.1111/his.14642. Histopathology. 2022. PMID: 35274753 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters